Market Cap 12.12B 238M 204M 190M 175M 328M 22.79B 335M 2.26B 880M 11.42B 894M 875M 37.82B P/E 2026 *
22x
P/E 2027 * 15.4x
Enterprise Value 14.13B 278M 238M 222M 204M 383M 26.58B 390M 2.63B 1.03B 13.32B 1.04B 1.02B 44.09B EV / Sales 2026 *
2.87x
EV / Sales 2027 * 2.45x
Free-Float
40.82%
Yield 2026 *
0.99%
Yield 2027 * 2.48%
1 day-2.26%
1 week-6.77%
Current month+14.77%
1 month+22.18%
3 months+18.13%
6 months+42.92%
Current year+81.98%
1 week 6.01
Extreme 6.01
6.66
1 month 4.97
Extreme 4.97
7.39
Current year 3.06
Extreme 3.06
7.39
1 year 3.02
Extreme 3.021992
7.39
3 years 0.99
Extreme 0.987462
7.39
5 years 0.8
Extreme 0.803863
7.39
10 years 0.8
Extreme 0.803863
7.39
Manager TitleAgeSince
Chief Executive Officer - 01/01/2011
Director of Finance/CFO - 01/08/2014
Director of Finance/CFO - 01/01/2019
Director TitleAgeSince
Director/Board Member 41 01/01/2018
Chairman 51 01/01/2011
Director/Board Member - 01/01/2011
Change 5-day change 1-year change 3-year change Capi.($)
-2.26%-6.77%+83.55%+478.79% 239M
-2.35%+3.62%+77.59%+127.76% 1,141B
-1.80%+2.66%+50.45%+60.78% 659B
-1.62%+4.88%+25.77%+75.18% 470B
+1.20%+2.62%+41.69%+46.21% 366B
-0.61%+2.10%+23.43%+40.38% 302B
+0.32%+3.25%+0.94%+13.25% 254B
-2.22%+3.77%+46.27%+66.33% 239B
-1.10%-0.70%-14.31%-53.04% 207B
-1.88%+5.05%+22.22%+91.09% 183B
Average -1.26%+3.03%+35.76%+94.67% 382.12B
Weighted average by Cap. -1.43%+4.31%+44.14%+72.06%

Financials

2026 *2027 *
Net sales 4.92B 96.76M 82.85M 77.3M 70.93M 133M 9.26B 136M 917M 357M 4.64B 363M 355M 15.36B 5.66B 111M 95.26M 88.88M 81.55M 153M 10.65B 156M 1.05B 411M 5.34B 418M 409M 17.66B
Net income 499M 9.81M 8.4M 7.83M 7.19M 13.51M 938M 13.78M 92.95M 36.23M 470M 36.83M 36.03M 1.56B 799M 15.7M 13.44M 12.54M 11.51M 21.63M 1.5B 22.05M 149M 58M 753M 58.95M 57.67M 2.49B
Net Debt 2.01B 39.52M 33.84M 31.57M 28.97M 54.44M 3.78B 55.51M 375M 146M 1.9B 148M 145M 6.27B 1.72B 33.85M 28.98M 27.04M 24.81M 46.63M 3.24B 47.55M 321M 125M 1.62B 127M 124M 5.37B
Logo Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E (RAMEDA) specializes in the manufacture and marketing of generic pharmaceutical products. The products include antibiotics, vitamins, analgesics, medicines for ophthalmological care, gastrointestinal, dermatological and cardiovascular diseases, food supplements, medical devices and veterinary products.
Employees
-
Date Price Change Volume
19/08/26 EGP 6.060 -2.26% 6,262,948
18/08/26 EGP 6.200 -4.17% 6,913,345
17/08/26 EGP 6.470 +3.52% 11,360,070
16/08/26 EGP 6.250 -3.70% 8,350,788
13/08/26 EGP 6.490 -0.15% 13,484,901
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
6.060EGP
Average target price
5.757EGP
Spread / Average Target
-5.01%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RMDA Stock